Clarification on Norepinephrine Formulation for Dosing in MIMIC-IV

[smoralesmd]

Prerequisites

• Put an X between the brackets on this line if you have done all of the following:
  • Checked the online documentation: https://mimic.mit.edu/
  • Checked that your issue isn't already addressed: https://github.com/MIT-LCP/mimic-code/issues?utf8=%E2%9C%93&q=

Description

In the MIMIC-IV v2.2 database the medication files contain dosing information for norepinephrine (NE) in mcg/kg/min. However, it is unclear from the data whether this dosing is reported in equivalent or original dose and for which of the norepinephrine formulation (norepinephrine bitartrate, norepinephrine tartrate, or norepinephrine base). In the prescription table there is some information but it is not really clear.

Request

I would like to request clarification on the type of norepinephrine formulation for which the dosing is reported in the MIMIC-IV database. Understanding this information is crucial for accurate interpretation and analysis of the medication data. This is particularly important now, as the topic of norepinephrine dosing and formulations is being extensively discussed in current articles and literature. At the very least, it would be useful to know which formulation and presentation is usually being used in BIDMC.

Thanks!